Watson Pharmaceuticals, Inc. (NYSE:WPI) recently announced that it has filed an abbreviated new drug application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its generic version of Warner Chilcott’s (NASDAQ:WCRX) Lo Loestrin FE. Approval has been sought to market the generic version of the drug for the prevention of pregnancy.
In response, Warner Chilcott filed a suit against Watson Pharma in an U.S. District Court, to prevent the latter from selling its generic … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards